GLP-1 developer Kailera, proteomics firm Alamar file for U.S. IPOsbusinessinsider·Mar 28 at 08:57 AMGRTX0.00%NBSE.ESC
US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activityRenaissanceCapital·Mar 27 at 05:24 PMIPFXU+0.86%SBIO-0.39%
Altamira Therapeutics Provides Business Update and First Half 2025 Financial ResultsAcceswire·Aug 29, 2025 at 06:30 AMCYTOF+10.76%
Altamira Therapeutics to Host First Half 2025 Financial Results and Business Update Call on August 29, 2025Acceswire·Aug 26, 2025 at 03:00 PMCYTOF+10.76%
Delisting of Securities of Blue Star Foods Corp.; Altamira Therapeutics Ltd.; Evergreen Corporation; Fresh2 Group Limited; Coliseum Acquisition Corp.; The Real Good Food Company, Inc.; Mynaric AG; byNordic Acquisition Corporation; Avinger Inc.; MultiMetaVerse Holdings Limited; Nature's Miracle Holding Inc.; and SPI Energy Co., Ltd. from the Nasdaq Stock MarketGlobeNewswire·Jun 11, 2025 at 03:05 PMSPIEF0.00%SPI0.00%
Altamira Therapeutics (OTCQB: CYTOF) reports 2024 financial results, focuses on expanding RNA delivery technology.Unusual Whales·Apr 30, 2025 at 07:22 AMCYTOF+10.76%
